Senior Director of Commercial Training at Scholar Rock designing disease and product education curriculums. Leading the commercial training team and driving engagement competencies for business success.

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
Our most advanced investigational product candidate, apitegromab (SRK-015), a
selective inhibitor of the activation of the growth factor myostatin in skeletal muscle, is in development for the treatment of spinal muscular atrophy, or SMA.
Following positive results from the TOPAZ Phase 2 trial in patients with Type 2 and Type 3 SMA, we are now advancing apitegromab development through SAPPHIRE, a randomized, double-blind, placebo-controlled, phase 3 clinical trial.
In addition, we are conducting our DRAGON Phase 1 proof-of-concept trial for SRK-181, a selective inhibitor of latent TGFβ1 activation, in patients with locally advanced and metastatic solid tumors.
Utilizing our proprietary platform, we are creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia.
Browse and apply for open jobs at Scholar Rock.
Senior Director of Commercial Training at Scholar Rock designing disease and product education curriculums. Leading the commercial training team and driving engagement competencies for business success.
Director, Field Force Operations at Scholar Rock, advancing commercial operations in biotech. Managing sales sizing, compensation, and analytics across the organization.
Senior Clinical Trial Manager overseeing operational aspects of clinical studies at Scholar Rock. Implementing project plans and coordinating team activities throughout the study lifecycle.